Association of variants in genes related to the immune response and obesity with BPH in CLUE II

被引:5
作者
Lopez, D. S. [1 ,2 ,3 ]
Peskoe, S. B. [1 ]
Tsilidis, K. K. [4 ]
Hoffman-Bolton, J. [5 ]
Helzlsouer, K. J. [1 ,5 ,6 ]
Isaacs, W. B. [7 ,8 ]
Smith, M. W. [9 ]
Platz, E. A. [1 ,7 ,8 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Univ Texas Houston, Sch Publ Hlth, Div Epidemiol, Houston, TX 77030 USA
[3] Univ Texas Houston, Sch Med, Div Urol, Houston, TX 77030 USA
[4] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece
[5] Johns Hopkins Bloomberg Sch Publ Hlth, George W Comstock Ctr Publ Hlth Res & Prevent, Hagerstown, MD USA
[6] Mercy Med Ctr, Prevent & Res Ctr, Baltimore, MD USA
[7] James Buchanan Brady Urol Inst, Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA
[8] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[9] Natl Human Genome Res Inst, Extramural Res Program, Rockville, MD USA
关键词
BENIGN PROSTATIC HYPERPLASIA; CANCER PREVENTION TRIAL; URINARY-TRACT SYMPTOMS; C-REACTIVE PROTEIN; SERUM ADIPONECTIN; METABOLIC DISEASE; PPAR-GAMMA; RISK; POLYMORPHISMS; INFLAMMATION;
D O I
10.1038/pcan.2014.36
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Chronic inflammation and obesity may contribute to the genesis or progression of BPH and BPH-associated lower urinary tract symptoms (LUTS). The influence of variants in genes related to these states on BPH has not been studied extensively. Thus, we evaluated the association of 17 single-nucleotide polymorphisms (SNPs) in immune response genes (IL18, IL6, IL8, 1L10, TNF, CRP, TLR4 and RNASEL) and genes involved in obesity, including insulin regulation (LEP, ADIPOQ, PPARG and TCF7L2), with BPH. METHODS: BPH cases (N=568) and age-frequency matched controls (N=568) were selected from among adult male CLUE II cohort participants who responded in 2000 to a mailed questionnaire. BPH was defined as BPH surgery, use of BPH medications or symptomatic BPH (American Urological Association Symptom Index Score 15). Controls were men who had not had BPH surgery, did not use BPH medications and whose symptom score was <= 7. Age-adjusted odds ratios (ORs) and 95% confidence intervals (as) were estimated using logistic regression. RESULTS: None of the candidate SNPs was statistically significantly associated with BPH. However, we could not rule out possible weak associations for CRP rs1205 (1082C>T), ADIPOQ rs1501299 (276C>A), PPARG rs1801282 (-49C>G) and TCF7L2 rs7903146 (47833T>C). After summing risk alleles, men with >= 4 had an increased BPH risk compared with those with <= 1 (OR, 1.78; 95% CI, 1.10-2.89; P-trend = 0.006). CONCLUSIONS: SNPs in genes related to immune response and obesity, especially in combination, may be associated with BPH.
引用
收藏
页码:353 / 358
页数:6
相关论文
共 32 条
[1]  
Ahima RS, 2008, FRONT HORM RES, V36, P182, DOI 10.1159/000115365
[2]   The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes [J].
Altshuler, D ;
Hirschhorn, JN ;
Klannemark, M ;
Lindgren, CM ;
Vohl, MC ;
Nemesh, J ;
Lane, CR ;
Schaffner, SF ;
Bolk, S ;
Brewer, C ;
Tuomi, T ;
Gaudet, D ;
Hudson, TJ ;
Daly, M ;
Groop, L ;
Lander, ES .
NATURE GENETICS, 2000, 26 (01) :76-80
[3]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[4]  
Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013
[5]   Correlation between benign prostatic hyperplasia and inflammation [J].
Bostanci, Yakup ;
Kazzazi, Amir ;
Momtahen, Shabnam ;
Laze, Juliana ;
Djavan, Bob .
CURRENT OPINION IN UROLOGY, 2013, 23 (01) :5-10
[6]   Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels [J].
Carlson, CS ;
Aldred, SF ;
Lee, PK ;
Tracy, RP ;
Schwartz, SM ;
Rieder, M ;
Liu, KA ;
Williams, OD ;
Iribarren, C ;
Lewis, EC ;
Fornage, M ;
Boerwinkle, E ;
Gross, M ;
Jaquish, C ;
Nickerson, DA ;
Myers, RM ;
Siscovick, DS ;
Reiner, AP .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (01) :64-77
[7]   RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases [J].
Casey, G ;
Neville, PJ ;
Plummer, SJ ;
Xiang, Y ;
Krumroy, LM ;
Klein, EA ;
Catalona, WJ ;
Nupponen, N ;
Carpten, JD ;
Trent, JM ;
Silverman, RH ;
Witte, JS .
NATURE GENETICS, 2002, 32 (04) :582-583
[8]   Cytokines in cancer pathogenesis and cancer therapy [J].
Dranoff, G .
NATURE REVIEWS CANCER, 2004, 4 (01) :11-22
[9]   Nutrition and benign prostatic hyperplasia [J].
Espinosa, Geovanni .
CURRENT OPINION IN UROLOGY, 2013, 23 (01) :38-41
[10]   TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program [J].
Florez, Jose C. ;
Jablonski, Kathleen A. ;
Bayley, Nick ;
Pollin, Toni I. ;
de Bakker, Paul I. W. ;
Shuldiner, Alan R. ;
Knowler, William C. ;
Nathan, David M. ;
Altshuler, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (03) :241-250